Natural anti-infective pulmonary proteins: In vivo cooperative action of surfactant protein SP-A and the lung antimicrobial peptide SP-BN

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1628-1636

  Coya, Juan Manuel ^a,b   Akinbi, Henry T ^c   Sáenz, Alejandra ^a,b   Yang, Li ^c   Weaver, Timothy E ^c   Casals, Cristina ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CYTOKINE; PROTEIN BINDING; RECOMBINANT PROTEIN; SURFACTANT ASSOCIATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG BINDING; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENTIATION; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LUNG HOMOGENATE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PH MEASUREMENT; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROTYPE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; KLEBSIELLA INFECTION; KNOCKOUT MOUSE; LUNG; MACROPHAGE; METABOLISM; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PH;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HUMANS; HYDROGEN-ION CONCENTRATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; PROTEIN BINDING; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RECOMBINANT PROTEINS;

EID: 84938946420     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500778     Document Type: Article

References (30)

1. Slama, T. G. 2008. Gram-negative antibiotic resistance: there is a price to pay. Crit. Care 12(Suppl. 4): S4.
2. Argyres, M. I. 2010. Hospital-acquired infections due to gram-negative bacteria. N. Engl. J. Med. 363: 1483, author reply 1483-1484.
3. Peters, B. M., M. E. Shirtliff, and M. A. Jabra-Rizk. 2010. Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog. 6: e1001067.
4. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5: 58-68.
5. Yang, L., J. Johansson, R. Ridsdale, H. Willander, M. Fitzen, H. T. Akinbi, and T. E. Weaver. 2010. Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J. Immunol. 184: 975-983.
6. Kuzmenko, A. I., H. Wu, S. Wan, and F. X. McCormack. 2005. Surfactant protein A is a principal and oxidation-sensitive microbial permeabilizing factor in the alveolar lining fluid. J. Biol. Chem. 280: 25913-25919.
7. Zhang, S., Y. Chen, E. Potvin, F. Sanschagrin, R. C. Levesque, F. X. McCormack, and G. W. Lau. 2005. Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A. PLoS Pathog. 1: 259-268.
8. Sánchez-Barbero, F., J. Strassner, R. Garc?a-Cañero, W. Steinhilber, and C. Casals. 2005. Role of the degree of oligomerization in the structure and function of human surfactant protein A. J. Biol. Chem. 280: 7659-7670.
9. Sáenz, A., A. López-Sánchez, J. Mojica-Lázaro, L. Mart?nez-Caro, N. Nin, L. A. Bagatolli, and C. Casals. 2010. Fluidizing effects of C-reactive protein on lung surfactant membranes: protective role of surfactant protein A. FASEB J. 24: 3662-3673.
10. Sánchez-Barbero, F., G. Rivas, W. Steinhilber, and C. Casals. 2007. Structural and functional differences among human surfactant proteins SP-A1, SP-A2 and co-expressed SP-A1/SP-A2: role of supratrimeric oligomerization. Biochem. J. 406: 479-489.
11. Llobet, E., J. M. Tomás, and J. A. Bengoechea. 2008. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154: 3877-3886.
12. Sarrias, M. R., S. Roselló, F. Sánchez-Barbero, J. M. Sierra, J. Vila, J. Yélamos, J. Vives, C. Casals, and F. Lozano. 2005. A role for human Sp alpha as a pattern recognition receptor. J. Biol. Chem. 280: 35391-35398.
13. Casals, C., E. Miguel, and J. Perez-Gil. 1993. Tryptophan fluorescence study on the interaction of pulmonary surfactant protein A with phospholipid vesicles. Biochem. J. 296: 585-593.
14. Akinbi, H. T., R. Epaud, H. Bhatt, and T. E. Weaver. 2000. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J. Immunol. 165: 5760-5766.
15. Lin, S., C. L. Na, H. T. Akinbi, K. S. Apsley, J. A. Whitsett, and T. E. Weaver. 1999. Surfactant protein B (SP-B)-/-mice are rescued by restoration of SP-B expression in alveolar type II cells but not Clara cells. J. Biol. Chem. 274: 19168-19174.
16. Yan, H., and R. E. Hancock. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45: 1558-1560.
17. Singh, P. K., B. F. Tack, P. B. McCray, Jr., and M. J. Welsh. 2000. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L799-L805.
18. Tripathi, S., T. Tecle, A. Verma, E. Crouch, M. White, and K. L. Hartshorn. 2013. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J. Gen. Virol. 94: 40-49.
19. Ahn, V. E., K. F. Faull, J. P. Whitelegge, A. L. Fluharty, and G. G. Privé. 2003. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl. Acad. Sci. USA 100: 38-43.
20. Cañadas, O., I. Garc?a-Verdugo, K. M. Keough, and C. Casals. 2008. SP-A permeabilizes lipopolysaccharide membranes by forming protein aggregates that extract lipids from the membrane. Biophys. J. 95: 3287-3294.
21. Mahalka, A. K., and P. K. Kinnunen. 2009. Binding of amphipathic alpha-helical antimicrobial peptides to lipid membranes: lessons from temporins B and L. Biochim. Biophys. Acta 1788: 1600-1609.
22. Jang, H., F. T. Arce, M. Mustata, S. Ramachandran, R. Capone, R. Nussinov, and R. Lal. 2011. Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. Biophys. J. 100: 1775-1783.
23. Frank, C. G., V. Reguerio, M. Rother, D. Moranta, A. P. Maeurer, J. Garmendia, T. F. Meyer, and J. A. Bengoechea. 2013. Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation. Cell. Microbiol. 15: 1212-1233.
24. Regueiro, V., D. Moranta, C. G. Frank, E. Larrarte, J. Margareto, C. March, J. Garmendia, and J. A. Bengoechea. 2011. Klebsiella pneumoniae subverts the activation of inflammatory responses in a NOD1-dependent manner. Cell. Microbiol. 13: 135-153.
25. Greenberger, M. J., S. L. Kunkel, R. M. Strieter, N. W. Lukacs, J. Bramson, J. Gauldie, F. L. Graham, M. Hitt, J. M. Danforth, and T. J. Standiford. 1996. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 157: 3006-3012.
26. Balamayooran, G., S. Batra, B. Theivanthiran, S. Cai, P. Pacher, and S. Jeyaseelan. 2012. Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/-mice. J. Immunol. 189: 5849-5859.
27. Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13: 159-175.
28. Niyonsaba, F., A. Suzuki, H. Ushio, I. Nagaoka, H. Ogawa, and K. Okumura. 2009. The human antimicrobial peptide dermcidin activates normal human keratinocytes. Br. J. Dermatol. 160: 243-249.
29. Mansour, S. C., O. M. Pena, and R. E. Hancock. 2014. Host defense peptides: front-line immunomodulators. Trends Immunol. 35: 443-450.
30. Reidy, M. F., and J. R. Wright. 2003. Surfactant protein A enhances apoptotic cell uptake and TGF-beta1 release by inflammatory alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L854-L861.